An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)

• Status: Terminated
• Trial end date: 2005-08-17
• Target enrollment: 0
• Participant gender: All

Summary

This is a study to evaluate the effectiveness and tolerability of a once-daily oral medication (MK-0873) for the treatment of COPD (chronic obstructive pulmonary disease) to determine whether the study drug leads to an improvement in pulmonary (lung) function, as well as symptoms, and quality of life.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: MK 0873

Criteria

Inclusion Criteria:

• Males and females, 40 to 75 years old, with a history consistent with COPD (chronic obstructive pulmonary disease)

• Lung function tests that meet the requirements of the study

Exclusion Criteria:

• Severe and unstable medical conditions other than COPD (chronic obstructive pulmonary disease)

• Use of continuous oxygen therapy

• Cardiac (heart) arrhythmias

• Other lung disease

• History of colitis (inflammation of the colon)